We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Black Grain Eumycetoma Causative Agents Identified by Molecular Method

By LabMedica International staff writers
Posted on 17 Dec 2014
Print article
Image: Histopathological appearance of Black Grain Eumycetoma caused by Madurella mycetomatis (Photo courtesy of Dr. Libero Ajello).
Image: Histopathological appearance of Black Grain Eumycetoma caused by Madurella mycetomatis (Photo courtesy of Dr. Libero Ajello).
A rapid, simple, and highly efficient molecular based method for identification of the causative agents of black grain eumycetoma has been introduced, aiming to improve diagnostics in endemic areas.

Accurate identification of mycetoma causative agent is a priority for treatment; however, current identification tools are far from being satisfactory for both reliable diagnosis and epidemiological investigations and the currently available molecular methods based on DNA sequencing though specific are extremely expensive.

Scientists at the University of Amsterdam (The Netherlands) collaborating with an international team, analyzed 62 isolates belonging to eight species causing black grain mycetoma: 32 Madurella mycetomatis, 1 M. fahalii , 3 M. pseudomycetomatis, 2 M. tropicana, 10 Trematosphaeria grisea, 6 Falciformispora senegalensis, 2 F. tompkinsii, and 6 Medicopsis romeroi. All strains were identified down to species level by sequencing of the ribosomal DNA (rDNA) internal transcribed spacer (ITS) region.

Rolling circle amplification (RCA) is a powerful diagnostic method based on detection of specific nucleic-acid sequences and enzymatic amplification of circularized oligonucleotide probes under isothermal conditions. The probes are linear oligonucleotides that contain two target-complementary sequences at their ends joined by linkers. The ends of the probe hybridize to the complementary target in juxtaposition and then ligate which allows the circularization of the probe. The circular structured molecule then amplifies with DNA polymerase that has strand displacement and progressive DNA synthesis activity resulting in series of repeats of the original circular template. After RCA, accumulated double stranded DNA was detected with an ultra violet (UV) transilluminator (Vilber Lourmat; Marne-la-Vallée, France).

RCA was used to identify 62 strains belonging to eight species causing human eumycetoma. Since black grain eumycetoma species are known to be phylogenetically distant, it was easy to find unique sites for their identification. The ribosomal ITS region was sufficient for identification of all species and showed no intraspecific variability within a set of 100 M. mycetomatis strains in the collection. With the isothermal RCA assay, the 62 isolates were successfully identified with 100% specificity and no cross reactivity or false results.

The authors concluded that RCA is extremely useful for specific identification of agents of mycetoma. Performance and rapid turnaround time features make the RCA suitable for quick and reliable diagnosis, which is an enormous improvement compared to the current phenotypic identification of mostly non-sporulating cultures. Future application of RCA could be the detection of agents DNA directly from clinical samples without requirement of culturing. The study was published on December 4, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

University of Amsterdam 
Vilber Lourmat 


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
Troponin I Test
Quidel Triage Troponin I Test

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.